# STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant

> **NCT06901466** · PHASE4 · RECRUITING · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 880 (estimated)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DRUG:** Experimental: Rivaroxaban monotherapy
- **DRUG:** Active Comparator: Rivaroxaban+Clopidogrel

## Key facts

- **NCT ID:** NCT06901466
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-13
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 880 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06901466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06901466, "STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06901466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*